Suchergebnisse - "Kiss, Róbert Gábor"

PubPharm (101)

1

The effect of kidney function on guideline-directed medical therapy implementation and prognosis in heart failure with reduced ejection fraction

enthalten in: Clinical cardiology | 2024

von Bánfi-Bacsárdi, F. | Pilecky, D. | Vámos, M. | +10

2

Transcatheter valvular interventions 2022 : insights from the National Societies of Cardiology Journals of the European Society of Cardiology

enthalten in: European heart journal | 2024

von Monsuez, J. | Gatzov, P. | Alfonso, F. | +16

3

High platelet adrenergic activity and concomitant activation of the pituitary/medullar axis as alarming laboratory parameters in ACS survivors-the STRESS-AMI study

enthalten in: Frontiers in cardiovascular medicine | 2024

von Gulyás, Z. | Horváth, Z. | Hajtman, L. | +5

4

The Impact of Specialised Heart Failure Outpatient Care on the Long-Term Application of Guideline-Directed Medical Therapy and on Prognosis in Heart Failure with Reduced Ejection Fraction

enthalten in: Diagnostics (Basel, Switzerland) | 2024

von Muk, B. | Bánfi-Bacsárdi, F. | Vámos, M. | +12

5

2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes

enthalten in: European heart journal | 2023

von Marx, N. | Federici, M. | Schütt, K. | +120

ErratumIn: Eur Heart J. 2023 Dec 21;44(48):5060. - PMID 37989571

6

The effect of kidney function on the optimization of medical therapy and on mortality in heart failure with reduced ejection fraction

enthalten in: Orvosi hetilap | 2023

von Bánfi-Bacsárdi, F. | Vámos, M. | Majoros, Z. | +6

7

The Optimization of Guideline-Directed Medical Therapy during Hospitalization among Patients with Heart Failure with Reduced Ejection Fraction in Daily Clinical Practice

enthalten in: Cardiology | 2023

von Bánfi-Bacsárdi, F. | Muk, B. | Pilecky, D. | +3

8

Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction-The REC-DUT-002 Trial

enthalten in: Journal of clinical medicine | 2022

von von Lewinski, D. | Benedikt, M. | Alber, H. | +12

9

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

enthalten in: Circulation | 2022

von Hagström, E. | Steg, P. | Szarek, M. | +117

CommentIn: Circulation. 2022 Aug 30;146(9):673-675. - PMID 36037269

10

Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes : Insights from the ODYSSEY OUTCOMES Trial

enthalten in: The American journal of medicine | 2022

von Lopes, R. | Guimarães, P. | Schwartz, G. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]